Assessment of discordance of treatment satisfaction between patients with rheumatoid arthritis in low disease activity or in remission and their treating physicians: A cross-sectional survey

References

• Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Koike T, Oda H, Yamamoto K, Miyasaka N, Harigai M, et al. Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan. Mod Rheumatol. 2015;25(1):43–9.
   PubMed Web of Science ®Google Scholar
• Raczkiewicz A, Juszkiewicz A, Tlustochowicz M, Tlustochowicz W. Polish rheumatologists and rheumatoid arthritis patients differ in their opinions about treatment inefficacy. Arch Rheumatol. 2015;30(3):238–43.
   Web of Science ®Google Scholar
• da Silva JA, Ramiro S, Pedro S, Rodrigues A, Vasconcelos JC, Benito-Garcia E. Patients- and physicians- priorities for improvement. The case of rheumatic diseases. Acta Reumatol Port 2010;35(2):192–9.
   PubMed Web of Science ®Google Scholar
• Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E, Kemhus M. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J. 2016;22(7).
   Google Scholar
• Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, et al. Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care Res (Hoboken). 2017;69(10):1606–11.
   PubMed Web of Science ®Google Scholar
• Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62(6):857–64.
   PubMed Web of Science ®Google Scholar
• Cho SK, for the KORONA investigators, Sung YK, Choi CB, Bang SY, Cha HS, Choe JY, et al. What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis? Mod Rheumatol. 2017;27(1):35–41.
   PubMed Web of Science ®Google Scholar
• Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R, Ancuta C, et al. Determinants of discordance in patients’ and physicians’ rating of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken). 2012;64(2):206–14.
   PubMed Web of Science ®Google Scholar
• Lindström Egholm C, Krogh NS, Pincus T, Dreyer L, Ellingsen T, Glintborg B, et al. Discordance of global assessments by patient and physician is higher in female than in male patients regardless of the physician’s sex: data on patients with rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis from the DANBIO registry. J Rheumatol. 2015;42(10):1781–5.
   PubMed Web of Science ®Google Scholar
• Nicolau G, Yogui MM, Vallochi TL, Gianini RJ, Laurindo IM, Novaes GS. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol 2004;31(7):1293–6.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Strand V, Koenig AS, Szumski A, Kotak S, Jones TV. Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity. Arthritis Res Ther. 2016;18(1):114.
   PubMedGoogle Scholar
• Ishida M, Kuroiwa Y, Yoshida E, Sato M, Krupa D, Henry N, et al. Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review. Mod Rheumatol. 2018;28(5):789–99.
   PubMed Web of Science ®Google Scholar
• Ishiguro N, Dougados M, Cai Z, Zhu B, Ishida M, Sato M, et al. Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: post hoc analyses of overall and Japanese results from two phase 3 clinical trials. Mod Rheumatol. 2018;28(6):950–9.
   PubMed Web of Science ®Google Scholar
• Gibofsky A, Galloway J, Kekow J, Zerbini C, de la Vega M, Lee G, et al.; RA NarRAtive global advisory panel. Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys. Health Qual Life Outcomes. 2018;16(1):211.
   PubMedGoogle Scholar
• Taylor PC, Alten R, Gomez-Reino JJ, Caporali R, Bertin P, Sullivan E, et al. Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment. RMD Open. 2018;4(1):e000615.
   PubMed Web of Science ®Google Scholar
• Ministry of Education, Culture, Sports, Science and Technology. Ethical guidelines concerning medical studies in human subjects. 2015 [last accessed 2019 Nov 4]. Available from: http://www.lifescience.mext.go.jp/files/pdf/n1500_02.pdf
   Google Scholar
• Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.
   PubMedGoogle Scholar
• Pincus T. A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care. Bull NYU Hosp Jt Dis. 2007;65(2):150–60.
   PubMedGoogle Scholar
• Pincus T, Yazici Y, Bergman M. Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S19–S28.
   PubMed Web of Science ®Google Scholar
• Yokogawa N, Kaneko T, Nagai Y, Nunokawa T, Sawaki T, Shiroto K, et al. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI. Mod Rheumatol. 2015;25(2):264–9.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.
   PubMed Web of Science ®Google Scholar
• Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012;64(5):640–7.
   PubMed Web of Science ®Google Scholar
• McWilliams DF, Walsh DA. Pain mechanisms in rheumatoid arthritis. Clin Exp Rheumatol 2017;35(5):94–101. Suppl 107
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–77.
   PubMed Web of Science ®Google Scholar
• González CM, Carmona L, de Toro J, Batlle-Gualda E, Torralba AI, Arteaga MJ, et al. Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products. Patient Prefer Adherence. 2017;11:1243–52.
   PubMed Web of Science ®Google Scholar
• Furst DE, Tran M, Sullivan E, Pike J, Piercy J, Herrera V, et al. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36(9):2045–54.
   PubMed Web of Science ®Google Scholar
• Aoki A, Suda A, Nagaoka S, Takeno M, Ishigatsubo Y, Ashizawa T, et al. Preferences of Japanese rheumatoid arthritis patients in treatment decision-making. Mod Rheumatol. 2013;23(5):891–6.
   PubMed Web of Science ®Google Scholar
• Mahlich J, Sruamsiri R. Preference for shared decision-making in Japanese patients with rheumatoid arthritis. Cogent Med 2017;4:1353262.
   Google Scholar
• Aoki A, Ohbu S. Japanese physicians’ preferences for decision making in rheumatoid arthritis treatment. Patient Prefer Adherence. 2016;10:107–13.
   PubMed Web of Science ®Google Scholar